B. Crestani (Paris, France), K. Antoniou (Heraklion, Greece)
Introduction
B. Crestani (Paris, France), K. Antoniou (Heraklion, Greece)
|  |
Progression of systemic sclerosis-associated ILD (SSc-ILD) and effect of nintedanib in subgroups by monocyte and neutrophil counts
M. Kreuter (Heidelberg, Germany), C. Denton (London, United Kingdom), L. Ho (Seattle, Washington, United States), R. Hoyles (Oxford, United Kingdom), I. Glaspole (Melbourne, Victoria, Australia), T. Suda (Hamamatsu, Japan), C. Miede ( Sulzbach (Taunus), Germany), M. Alves (Ingelheim am Rhein, Germany), T. Maher (Los Angeles, CA, United States)
|    |
Cohort enrichment strategies for progressive interstitial lung disease in systemic sclerosis from EUSTAR
A. Hoffmann-Vold (Oslo, Norway), C. Brunborg (Oslo, Norway), P. Airò (Brescia, Italy), L. Ananyeva (Moscow, Russian Federation), L. Czirják (Pécs, Hungary), S. Guiducci (Florence, Italy), E. Hachulla (Lille, France), M. Li (Peking, Chad), C. Mihai (Zurich, Switzerland), G. Riemekasten (Lübeck, Germany), P. Sfikakis (Athens, Greece), G. Valentini (Napoli, Italy), O. Kowal-Bielecka (Bialystok, Poland), Y. Allanore (Paris, France), O. Distler (Zurich, Switzerland)
| |
Plasma-derived exosomal miRNAs as non-invasive biomarkers for lung involvement in systemic sclerosis
M. Njock (Liège, Belgium), M. Henket (Liège, Belgium), P. Jacquerie (Liège, Belgium), C. Moermans (Liège, Belgium), D. De Seny (Liège, Belgium), M. Malaise (Liège, Belgium), R. Louis (Liège, Belgium), J. Guiot (Liège, Belgium)
| |
Extensive autoantibody panel in Systemic sclerosis associated Interstitial Lung Disease
C. Stock (London, United Kingdom), B. Seeliger (Hannover, Germany), P. Cameli (Siena, Italy), M. Kokosi (London, United Kingdom), V. Kouranos (London, United Kingdom), P. George (London, United Kingdom), P. Molyneaux (London, United Kingdom), F. Chua (London, United Kingdom), V. Ong (London, United Kingdom), D. Abraham (London, United Kingdom), C. Denton (London, United Kingdom), G. Jenkins (London, United Kingdom), A. Wells (London, United Kingdom), J. Donovan (London, United Kingdom), E. Bargagli (Siena, Italy), A. Prasse (Hannover, Germany), T. Witte (Hannover, Germany), E. Renzoni (London, United Kingdom)
| |
Persistent inflammation in systemic sclerosis is strongly associated with mortality: a EUSTAR database analysis
S. Guler (Bern, Switzerland), A. Sarbu (Bern, Switzerland), O. Stadler (Bern, Switzerland), Y. Allanore (Paris, France), V. Bernardino (Lisboa, Portugal), J. Distler (Erlangen, Germany), A. Gabrielli (Ancona, Italy), A. Hoffmann-Vold (Oslo, Norway), M. Matucci-Cerinic (Florence and Milano, Italy), U. Müller-Ladner (Bad Nauheim, Germany), V. Ortiz-Santamaria (Granollers, Spain), S. Rednic (Cluj-Napoca, Romania), V. Riccieri (Roma, Italy), V. Smith (Gent, Belgium), S. Ullman (Bispebjerg, Denmark), U. Walker (Basel, Switzerland), T. Geiser (Bern, Switzerland), O. Distler (Zürich, Switzerland), B. Maurer (Bern, Switzerland), F. Kollert (Bern, Switzerland)
| |
Effects of nintedanib in patients with systemic sclerosis-associated ILD (SSc-ILD) and differing levels of lung function impairment
A. Wells (London, United Kingdom), W. Wuyts (Leuven, Belgium), S. Gläser (Berlin, Germany), A. Guillen-Del-Castillo (Barcelona, Spain), H. Nunes (Bobigny, France), M. Okamoto (Kurume, Japan), R. Simonovska (Sulzbach (Taunus), Germany), M. Alves (Ingelheim am Rhein, Germany), K. Highland (Cleveland, OH, United States)
| |
Lung involvement in early rheumatoid arthritis, interim analysis of the FINDRA prospective study
M. Perrot (Bruxelles, Belgium), B. Ghaye (Bruxelles, Belgium), D. Zan (Bruxelles, Belgium), A. Avramovska (Bruxelles, Belgium), M. Stoenoiu (Bruxelles, Belgium), M. Doyen (Bruxelles, Belgium), S. Koenig (Bruxelles, Belgium), P. Durez (Bruxelles, Belgium), A. Froidure (Bruxelles, Belgium), A. Froidure (Bruxelles, Belgium)
| |
Serum KL-6 improves prediction of progressive phenotype (PP) at one year independently of underlying interstitial lung disease (ILD): results from the VAMOS study.
F. Bonella (Essen, Germany), M. Vegas Sanchez (Madrid, Spain), D. Castillo Villegas (Barcelona, Spain), P. Millan-Billi (Barcelona, Spain), E. Gottstein (Essen, Germany), O. Sánchez Pernaute (Madrid, Spain), E. Bargagli (Siena, Italy), M. Molina Molina (Barcelona, Spain)
| |
Predictors of Interstitial Lung Disease (ILD) in patients with Idiopathic Inflammatory Myopathy-associated (IIM)
E. Cocconcelli (Padova, Italy), E. Zanatta (Padova, Italy), S. Bellani (Padova, Italy), G. Castelli (Padova, Italy), S. Petrarulo (Padova, Italy), L. Iaccarino (Padova, Italy), P. Spagnolo (Padova, Italy), E. Balestro (Padova, Italy), E. Balestro (Padova (PD), Italy)
| |